Drug Discovery Science Industry Insights | Page 5

A selection of different drugs on top of a yellow tape measure used for measuring weight loss.

Industry Insight

Beyond the Scale: How Targeted Weight Loss Transforms Metabolic Health and Lowers Healthcare Costs

Weight loss isn’t just cosmetic; it prevents chronic disease, saves money and improves mental and physical well-being. Explore the latest weight loss research and learn how even moderate weight loss can transform metabolic health.

A digital illustration depicted a number of small molecule structures, with a glass-like appearance.

Industry Insight

Advancing Small Molecule Analysis For PFAS, Drugs and Contamination Detection

Learn how Bruker’s latest innovations are enhancing small molecule analysis for toxicology and environmental analysis.

Cryogenic sample storage with gloved hand retrieving a labeled vial from liquid nitrogen.

Industry Insight

Building Agility, Compliance and Sustainability in Sample Storage

In this interview, discover how Astoriom's Integrated Stability & Sustainability Outsourcing Model addresses traditional storage challenges and enables biopharma companies to respond more nimbly to disruptions.

Illustration of green microscopic bacteria and viruses.

Industry Insight

Harnessing the Immune System To Combat Antimicrobial Resistance

Dr. Jennifer Schneider discusses Centauri Therapeutics' novel approach to combating Gram-negative infections, its first clinical candidate from the ABX-01 program and how the platform could help shape the future of anti-infective therapy.

A researcher holding up a hologram of a molecule in a pill, representing AI-driven anti-infective discovery.

Industry Insight

Anti-Infective Development Boosted by AI and Automation

Anti-infective discovery is evolving with AI and robotics – learn how UK researchers aim to cut development time and improve success rates.

An adult holding a baby's hand, signifying the first patient to receive a customized gene therapy was a child.

Industry Insight

How the First Customized Gene Therapy Was Created in Six Months

We spoke with the developers and manufacturers of the CRISPR gene therapy used to treat KJ Muldoon’s rare genetic condition, CPS1, about how the product was created in just six months.

Stethoscope on clipboard with digital health icons symbolizing AI in healthcare technology.

Industry Insight

Precision Medicine at Novo Nordisk Uses AI To Combat Obesity

Novo Nordisk’s Transformational Prevention Unit (TPU) integrates AI, omics, and genomics to predict obesity risk and tailor interventions. By focusing on personalized solutions, TPU aims to prevent obesity and reduce the incidence of related diseases

3D molecular rendering of a protein structure illustrating complexity in proteomics research.

Industry Insight

Unlocking Next-Gen Capabilities in LC-MS-Based Proteomics

In this interview, Morten Bern, chief executive officer of Evosep, discusses the innovations behind the Eno system, the evolving needs of pharmaceutical customers and the growing focus on high-throughput, high-sensitivity proteomics solutions.

Illustration of the gut on sky blue background with various bacteria inside it, representing the gut microbiome.

Industry Insight

A Nutrient-Based Alternative to Weight Loss Drugs

Unlike injectable weight loss drugs that often serve as a temporary fix, Elcella seeks to naturally activate the gut’s own appetite-regulating mechanisms, offering a new path to long-term health and sustainable weight management.